Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950170-25-062927
Filing Date
2025-05-02
Accepted
2025-05-02 17:14:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 rkda-425_amend_exchg_agr.htm 425 49129
2 EX-2.1 rkda-ex2_1.htm EX-2.1 30371
  Complete submission text file 0000950170-25-062927.txt   81172
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filed by) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)

Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Subject) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37383 | Film No.: 25909912
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)